# SCEMBLIX

NDC: 0078-1098
Generic name: asciminib
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20211029

FDA application: NDA215358

## Active ingredients

- ASCIMINIB HYDROCHLORIDE: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-1098"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-1098
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e33001e7-3650-42b1-ae56-cddb5c43aa2b